Q/C TECHNOLOGIES, INC. — Director's Dealing 2015

Dec 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2015-12-11

Reporting Person: RAUCH GARY M (VP - Finance, Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-11	Common Stock, no par value per share	P	3500	$1.50	Acquired	5000	Direct